Dermatology News

Guselkumab administered once every 4 or 8 weeks improved axial outcomes in patients with psoriatic arthritis who have sacroiliitis through week 52, according to data published in The Lancet Rheumatology.

Including Black, Indigenous and people of color is necessary in photographs and studies of cutaneous reactions after the mRNA COVID-19 vaccines, according to correspondence published in The New England Journal of Medicine.

COVID-19-associated hospitalization was more common in patients who were taking oral methotrexate but not in those taking biologics, according to a study.

A 10-year-old girl is brought to your clinic by her mother, complaining of left-sided facial swelling with mild-to-moderate pain.

Burnout is a growing problem in the medical community and, as pressure builds, has a negative impact on practitioners.

On May 11, Icelandic-based drug developer Alvotech filed a lawsuit against AbbVie seeking to undo what it alleges is a “minefield” of “invalid” patents surrounding what is arguably the pharma giant’s most prized possession: Humira.

A 3-year-old boy presented to the dermatology clinic with a rash on his right leg. The rash started 3 months earlier as a single lesion, then a second lesion developed a few weeks later.

StrataGraft, a bioengineered bilayer construct designed to mimic human skin, has been approved by the FDA for the treatment of thermal burns in which intact dermal elements remain and surgical intervention is indicated.

Patients with psoriasis or psoriatic arthritis treated with ustekinumab demonstrated a 1.4- to 3-times lower risk for hospitalization with serious infections than those who received other biologics or apremilast, according to data.

The FDA has expanded its approval of the Recell system in combination with meshed autografting to include treatment of acute full-thickness thermal burn wounds in pediatric patients, Avita Medical announced in a press release.